Related Experiment Videos
Catheter complications: a boy with iatrogenic disease
Journal of the Royal Society of Medicine
|January 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
No clinical evidence of hidden vCJD in UK children.
Archives of disease in childhood·2005
Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.
Archives of disease in childhood·2005
Is variant Creutzfeldt-Jakob disease in young children misdiagnosed as Alpers' syndrome? An analysis of a national surveillance study.
Journal of neurology, neurosurgery, and psychiatry·2004
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Ethnic differences in specialty destinations in UK medicine: a repeated cross-sectional analysis of secondary data.
Journal of the Royal Society of Medicine·2026
Medical screening of elderly heads of state.
Journal of the Royal Society of Medicine·2026
Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.
Journal of inherited metabolic disease·2026
Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.
Journal of the American Heart Association·2026
Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.
ACS medicinal chemistry letters·2026